CN1035923C - 制备亲脂寡糖抗生素盐组合物的方法 - Google Patents

制备亲脂寡糖抗生素盐组合物的方法 Download PDF

Info

Publication number
CN1035923C
CN1035923C CN92112388A CN92112388A CN1035923C CN 1035923 C CN1035923 C CN 1035923C CN 92112388 A CN92112388 A CN 92112388A CN 92112388 A CN92112388 A CN 92112388A CN 1035923 C CN1035923 C CN 1035923C
Authority
CN
China
Prior art keywords
formula
hydroxypropyl
cyclodextrin
antibiotic
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN92112388A
Other languages
English (en)
Chinese (zh)
Other versions
CN1073359A (zh
Inventor
M·帕特尔
V·P·古洛
R·赫尔
D·洛本堡
J·B·摩顿
G·H·米勒
H·Y·邝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CN1073359A publication Critical patent/CN1073359A/zh
Application granted granted Critical
Publication of CN1035923C publication Critical patent/CN1035923C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
CN92112388A 1991-10-16 1992-10-15 制备亲脂寡糖抗生素盐组合物的方法 Expired - Fee Related CN1035923C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77786491A 1991-10-16 1991-10-16
US777,864 1991-10-16

Publications (2)

Publication Number Publication Date
CN1073359A CN1073359A (zh) 1993-06-23
CN1035923C true CN1035923C (zh) 1997-09-24

Family

ID=25111545

Family Applications (1)

Application Number Title Priority Date Filing Date
CN92112388A Expired - Fee Related CN1035923C (zh) 1991-10-16 1992-10-15 制备亲脂寡糖抗生素盐组合物的方法

Country Status (27)

Country Link
US (1) US5624914A (OSRAM)
EP (2) EP0610295A1 (OSRAM)
JP (1) JP2614407B2 (OSRAM)
KR (1) KR100249584B1 (OSRAM)
CN (1) CN1035923C (OSRAM)
AT (1) ATE156019T1 (OSRAM)
AU (1) AU678344B2 (OSRAM)
CA (1) CA2121345C (OSRAM)
DE (1) DE69221252T2 (OSRAM)
DK (1) DK0538011T3 (OSRAM)
ES (1) ES2104845T3 (OSRAM)
FI (1) FI941723A0 (OSRAM)
GR (1) GR3024800T3 (OSRAM)
HK (1) HK1001085A1 (OSRAM)
HR (1) HRP921069B1 (OSRAM)
HU (1) HUT75157A (OSRAM)
IL (1) IL103446A (OSRAM)
MX (1) MX9205922A (OSRAM)
NO (1) NO307326B1 (OSRAM)
NZ (1) NZ244735A (OSRAM)
PH (1) PH31675A (OSRAM)
PL (1) PL170591B1 (OSRAM)
SI (1) SI9200260A (OSRAM)
TW (1) TW221378B (OSRAM)
WO (1) WO1993007904A1 (OSRAM)
YU (1) YU48722B (OSRAM)
ZA (1) ZA927923B (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948688A (en) * 1991-10-16 1999-09-07 Schering Corporation Method of determining monomeric drug content
US6380172B1 (en) 1991-10-16 2002-04-30 Schering Corporation Monomeric lipophilic oligosaccharide antibiotic compositions
US5652226A (en) * 1995-12-22 1997-07-29 Schering Corporation Water soluble antibiotics
US5776912A (en) * 1996-12-20 1998-07-07 Schering Corporation Lipophilic oligosaccharide antibiotic compositions
US5763600A (en) * 1997-04-18 1998-06-09 Schering Corporation Oligosaccharide antibiotics and process for preparation thereof
BR9815388A (pt) * 1997-10-03 2001-08-21 Galenica Pharmaceuticals Inc Polissacarìdeos formadores de iminas, sua preparação e seu uso como adjuvantes e imunoestimulantes
US6162910A (en) * 1998-11-30 2000-12-19 Schering Corporation Process for preparing lipophilic oligosaccharide antibiotics
US6320044B1 (en) 1998-12-18 2001-11-20 Schering Corporation Process for recovering lipophilic oligosaccharide antibiotics
PE20001370A1 (es) * 1998-12-18 2000-12-09 Schering Corp Proceso para recuperar antibioticos oligosacaridos lipofilicos
AU2003201A (en) * 1999-12-01 2001-06-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel use of lung surfactant
US6861513B2 (en) 2000-01-12 2005-03-01 Schering Corporation Everninomicin biosynthetic genes
ES2316445T3 (es) * 2000-05-02 2009-04-16 Theravance, Inc. Composicion que contiene una ciclodextrina y un antibiotico glicopeptidico.
US6699505B2 (en) * 2000-10-17 2004-03-02 Massachusetts Institute Of Technology Method of increasing the efficacy of antibiotics by compexing with cyclodextrins
DE10109166A1 (de) * 2001-02-25 2002-09-12 Combinature Biopharm Ag Avilamycin-Derivate
MXPA06010592A (es) * 2004-03-17 2007-06-12 Panacos Pharmaceuticals Inc Sales farmaceuticas de acido 3-o-(3',3'-dimetilsuccinil) betulinico.
EP1977874A3 (en) * 2004-12-01 2008-10-15 Nitto Denko Corporation Foam Filling Member
JP2008535923A (ja) * 2005-04-12 2008-09-04 パナコス ファーマシューティカルズ インコーポレーティッド ３−ｏ−（３’，３’−ジメチルスクシニル）ベツリン酸ジ−ｎ−メチル−ｄ−グルカミンの多形
WO2009035707A1 (en) * 2007-09-14 2009-03-19 Acambis Inc. Pharmaceutical compositions containing clostridium difficile toxoids a and b
JP2010095454A (ja) * 2008-10-14 2010-04-30 Cyclochem:Kk 抗菌組成物
EP2663338B1 (en) * 2011-01-14 2024-03-06 Emory University Glucose-based oligosaccharides comprising a positron-emitting radionuclide and their use for imaging
CA2988529A1 (en) 2015-06-10 2016-12-15 Vtesse, Inc. Hydroxypropyl beta-cyclodextrin compositions and methods
CN106317143B (zh) * 2016-08-23 2020-10-30 河北圣雪大成制药有限责任公司 一种提取阿维拉霉素的方法
KR20240160120A (ko) 2022-02-18 2024-11-08 베렌 테라퓨틱스 피.비.씨. 하이드록시프로필-베타-사이클로덱스트린의 조성물 및 이의 정제 방법
CN117024611B (zh) * 2023-03-01 2024-05-17 中国科学院南海海洋研究所 寡糖类抗生素everninomicin高产菌株的构建及活性的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002767A1 (en) * 1983-12-21 1985-07-04 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
US4622314A (en) * 1985-10-15 1986-11-11 Schering Corporation Substituted oligosaccharide antibiotics
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR128F (OSRAM) * 1962-04-02
US3915956A (en) * 1973-07-09 1975-10-28 Schering Corp Reduction products of everninomicins and methods for their manufacture
US3920629A (en) * 1973-09-19 1975-11-18 Schering Corp Desevernitrose everninomicins and method for their manufacture
US4006225A (en) * 1973-10-31 1977-02-01 Schering Corporation Method of using reduction products of everninomicins as antibacterial agents and pharmaceutical compositions useful therefor
US3998708A (en) * 1976-01-19 1976-12-21 Schering Corporation Electrochemical process for preparing hydroxylaminoeverninomicins
US4027016A (en) * 1976-01-19 1977-05-31 Schering Corporation Everninomicin antibacterial derivatives, electrochemical method for their manufacture, method for their use as antibacterial agents, and pharmaceutical compositions useful therefor
US4129720A (en) * 1977-02-14 1978-12-12 Schering Corporation Aminoeverninomicin and derivatives thereof
US4597968A (en) * 1982-08-06 1986-07-01 Schering Corporation Antibiotic 13-384 complex from Micromonospora carbonacea var africana
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4735903A (en) * 1984-06-21 1988-04-05 Schering Corporation Micromonospora carbonacea var africana
US4870060A (en) * 1985-03-15 1989-09-26 Janssen Pharmaceutica Derivatives of γ-cylodextrin
US4767748A (en) * 1985-10-15 1988-07-30 Schering Corporation Substituted oligosaccharide antibodies
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002767A1 (en) * 1983-12-21 1985-07-04 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4622314A (en) * 1985-10-15 1986-11-11 Schering Corporation Substituted oligosaccharide antibiotics

Also Published As

Publication number Publication date
YU48722B (sh) 1999-07-28
CA2121345A1 (en) 1993-04-29
HUT75157A (en) 1997-04-28
DK0538011T3 (da) 1997-09-08
MX9205922A (es) 1994-08-31
AU678344B2 (en) 1997-05-29
NO941276L (no) 1994-04-08
PH31675A (en) 1999-01-18
PL170591B1 (pl) 1997-01-31
TW221378B (OSRAM) 1994-03-01
FI941723A7 (fi) 1994-04-14
ZA927923B (en) 1993-04-26
HU9401104D0 (en) 1994-07-28
ES2104845T3 (es) 1997-10-16
NZ244735A (en) 1995-12-21
ATE156019T1 (de) 1997-08-15
EP0538011B1 (en) 1997-07-30
YU92192A (sr) 1996-01-09
HRP921069A2 (en) 1994-12-31
DE69221252D1 (de) 1997-09-04
IL103446A0 (en) 1993-03-15
HRP921069B1 (en) 1999-12-31
DE69221252T2 (de) 1998-01-22
FI941723A0 (fi) 1994-04-14
NO941276D0 (no) 1994-04-08
NO307326B1 (no) 2000-03-20
EP0538011A1 (en) 1993-04-21
CA2121345C (en) 1998-08-25
SI9200260A (en) 1993-06-30
JP2614407B2 (ja) 1997-05-28
HK1001085A1 (en) 1998-05-22
EP0610295A1 (en) 1994-08-17
GR3024800T3 (en) 1998-01-30
CN1073359A (zh) 1993-06-23
AU2780692A (en) 1993-05-21
KR100249584B1 (ko) 2000-04-01
IL103446A (en) 1997-02-18
US5624914A (en) 1997-04-29
WO1993007904A1 (en) 1993-04-29
JPH06510546A (ja) 1994-11-24

Similar Documents

Publication Publication Date Title
CN1035923C (zh) 制备亲脂寡糖抗生素盐组合物的方法
HK1001085B (en) Lipophilic oligosaccharide antibiotic salt compositions
CN1223378C (zh) 含有糖肽抗生素和环糊精的药物组合物
CN1055093C (zh) 葡糖胺二糖类、其制备方法和用途、以及含有这些二糖的药物组合物
CN1291239A (zh) 细胞抑制剂及其晶形的发酵制备方法
CN1705683A (zh) 与透明质酸或透明质酸衍生物共价键合的紫杉烷
CN1315961A (zh) 糖肽衍生物或含有它们的药物组合物
CN1173206A (zh) 含有链球菌脂磷壁酸质的抗肿瘤和抗胆固醇制剂
CN1111532A (zh) 含有提高了水溶解度的非水溶性或微水溶性化合物的组合物
JP2001508416A (ja) 親油性（ｌｉｐｏｐｈｉｌｉｃ）オリゴ糖抗生物質およびアルブミンを含む組成物
CN1694713A (zh) oxazaphosphorine和美司钠的液态稳定组合物
JP2001500901A (ja) 抗腫瘍および駆虫剤を溶解するために特に利用されるチオウレイド―シクロデキストリン、およびその製造方法
US20040209336A1 (en) Fermentation and purification of migrastatin and analog
CN1837229A (zh) 克拉霉素衍生物及其制备方法和药物应用
CN101081860B (zh) 多烯类抗生素双酯化合物
CN1080310C (zh) 抗生素wap-8294a1、a2、a4、ax-8、ax-9和ax-13
JPH01168700A (ja) 新規な抗生物質
JPS62174099A (ja) 新規グリコペプチド系抗生物質ｐａ−４２８６７−ａおよびｐａ−４２８６７−ｂとその製造方法
HK1085129A (en) Liquid stable composition of oxazaphosphorine with mesna
CN1993313A (zh) 抗菌化合物
FR2484424A1 (fr) Nouveau compose polymerique, mf-300, possedant une activite protectrice vis-a-vis des infections bacteriennes, sa preparation et ses utilisations
JPH06102018B2 (ja) 新規グリコペプチド系抗生物質ｐａ−４２８６７−ａおよびｐａ−４２８６７−ｂ産生微生物
JPH0258280B2 (OSRAM)
PT1390056E (pt) Antibióticos glicopéptidos
JPH0776593A (ja) アミノ糖活性物質、その製造方法及び医薬としてのその使用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee